<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The survival of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients without detectable circulating CFU-GM (median = 188 days) was significantly lower than those in whose peripheral blood CFU-GM were detected (median greater than 1000 days) (p less than 0.01) </plain></SENT>
<SENT sid="1" pm="."><plain>About half of those with detectable PB-CFU-GM died within 2 yr whilst the remainder survived more than ca 3 yr </plain></SENT>
<SENT sid="2" pm="."><plain>There was no significant difference in the distribution of patients having 0-5% and greater than 5% marrow blast cells within the three groups </plain></SENT>
</text></document>